Navigation Links
Diagnostic Imaging Market Partnering Terms and Agreements - a New Research Report Available at ReportsnReports.com
Date:8/6/2014

Dallas, Texas (PRWEB) August 06, 2014

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

The “Diagnostic Imaging Partnering Terms and Agreements” report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering:

  •     Imaging
  •     CT
  •     Endoscope
  •     Molecular and nuclear
  •     PET
  •     SPECT
  •     MRI
  •     Ultrasound
  •     X ray
  •     Angiography
  •     Fluoroscopy
  •     Mammography

This report provides an overview of diagnostic imaging dealmaking, the common clauses, rights and options in the partnering agreement, and also a comprehensive review of deals signed in since 2009.

Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=293408.

This report provides a comprehensive and detailed review of all diagnostic imaging deals announced since 2009. The comprehensive agreements chapter is organized by company A-Z, stage of development at signing, deal type, and therapy focus. Each deal title links via Weblink to an online version of the actual deal at Current Agreements deals and alliances database, providing easy access to each deal on demand. Where available, the full deal contract document is also provided and indicated by a document symbol.

Contract documents provide unsurpassed access to the detail of a deal normally announced in brief summary through a press release. Detailed analysis of a contract allow better understanding of the terms agreed between the parties, and importantly the basis under which monies and licensing rights are exchanged.

For example, analyzing actual company agreements allows assessment of the following:

  •     What is actually granted by the agreement to the partner company?
  •     What exclusivity is granted?
  •     What are the precise rights granted or optioned?
  •     What is the payment structure for the deal?
  •     How aresalesand payments audited?
  •     What is the deal term?
  •     How are the key terms of the agreement defined?
  •     How are IPRs handled and owned?
  •     Who is responsible for commercialization?
  •     Who is responsible for development, supply, and manufacture?
  •     How is confidentiality and publication managed?
  •     How are disputes to be resolved?
  •     Under what conditions can the deal be terminated?
  •     What happens when there is a change of ownership?
  •     What sublicensing and subcontracting provisions have been agreed?
  •     Which boilerplate clauses does the company insist upon?
  •     Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  •     Which jurisdiction does the company insist upon for agreement law?

Diagnostic Imaging Partnering Terms and Agreements includes:

  •     Trends in diagnostic imaging dealmaking in the biopharma industry since 2009
  •     Analysis of diagnostic imaging deal structure
  •     Access to headline, upfront, milestone and royalty data
  •     Case studies of real-life diagnostic imaging deals
  •     Access to over 700 diagnostic imaging deal documents
  •     The leading vaccine deals by value since 2009
  •     Most active diagnostic imaging dealmakers since 2009
  •     The leading diagnostic imaging partnering resources

In Diagnostic Imaging Partnering Terms and Agreements, the available contracts are listed by:

  •     Company A-Z
  •     Headline value
  •     Stage of development at signing
  •     Deal component type
  •     Therapy target
  •     Specific technology type

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive access to available deals and contract documents for over 700 diagnostic imaging deals. Analyzing actual contract agreements allows assessment of the following:

  •     What are the precise vaccine rights granted or optioned?
  •     What is actually granted by the agreement to the partner company?
  •     What exclusivity is granted?
  •     What is the payment structure for the deal?
  •     How are sales and payments audited?
  •     What is the deal term?
  •     How are the key terms of the agreement defined?
  •     How are IPRs handled and owned?
  •     Who is responsible for commercialization?
  •     Who is responsible for development, supply, and manufacture?
  •     How is confidentiality and publication managed?
  •     How are disputes to be resolved?
  •     Under what conditions can the deal be terminated?
  •     What happens when there is a change of ownership?
  •     What sublicensing and subcontracting provisions have been agreed?
  •     Which boilerplate clauses does the company insist upon?
  •     Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  •     Which jurisdiction does the company insist upon for agreement law?

Other New Reports:
Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics.

Co-Development Terms and Agreements in Pharma, Biotech and Diagnostics.

These reports contain links to online copies of actual collaborative R&D contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.

About US
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email the details on sales at reportsandreports.com.

Read the full story at http://www.prweb.com/releases/diagnostic-imaging/partnering-deals-report/prweb12075773.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
2. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
3. Diagnostic yield of colonoscopy for melena after nondiagnostic upper endoscopy is lower than previously reported
4. Range of diagnostic spinal fluid tests needed to differentiate concurrent brain diseases
5. Screening for breast cancer without X-rays: Lasers and sound merge in promising diagnostic technique
6. A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening
7. UGA researchers develop rapid diagnostic test for pathogens, contaminants
8. AMA adopts diagnostic ultrasound utilization and education resolution
9. A new genre of diagnostic tests for the era of personalized medicine
10. Diagnostic imaging increases among stage IV cancer patients on Medicare
11. Racial differences in diabetes diagnostic thresholds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Los ... two episodes of WE TV’s “Mama June: From Not to Hot,” which will begin ... notable, “Mama” June Shannon, known to millions from the 2012 reality television series, “Here ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... content provider for the National Institute for Health and Care Excellence ... organizations in the National Health Service (NHS) to search, order and purchase medical ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... exciting, new, interactive publication where generations converge and explore the world from different ... worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and find greater ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare Research & ... in the fight against cancer, has produced a seminal study that asked cancer ... release top-line findings in a webinar, Defining Compassionate Care Through the Voices of ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... offering. ... Menopause Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... following questions: What are the key drugs ... the Global Menopause market? What are the unit prices ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology: